15d-Prostaglandin J2 protects brain from ischemia-reperfusion injury
15d-Prostaglandin J2 protects brain from ischemia-reperfusion injury
复制标题
DOI:
10.1161/01.atv.0000201933.53964.5b
复制
发表时间:
2006-03-01
影响因子:
8.7
通讯作者:
Wu, KK
中科院分区:
文献类型:
--
作者:
Lin, TN;Cheung, WM;Wu, KK
Objective-Brain expresses abundant lipocalin-type prostaglandin (PG) D-2 (PGD(2)) synthase but the role of PGD2 and its metabolite, 15-deoxy-Delta(12.14) PGJ(2) (15d- PGJ(2)) in brain protection is unclear. The aim of this study is to assess the effect of 15d- PGJ2 on neuroprotection.Methods and Results-Adenoviral transfer of cyclooxygenase-1 (Adv-COX-1) was used to amplify the production of 15d- PGJ2 in ischemic cortex in a rat focal infarction model. Cortical 15d- PGJ2 in Adv-COX-1-treated rats was increased by 3-fold over control, which was correlated with reduced infarct volume and activated caspase 3, and increased peroxisome proliferator activated receptor-gamma (PPAR gamma) and heme oxygenase-1 (HO-1). Intraventricular infusion of 15d- PGJ2 resulted in reduction of infarct volume, which was abrogated by a PPAR gamma inhibitor. Rosiglitazone infusion had a similar effect. 15d- PGJ2 and rosiglitazone at low concentrations suppressed H2O2-induced rat or human neuronal apoptosis and necrosis and induced PPAR gamma and HO-1 expression. The anti-apoptotic effect was abrogated by PPAR gamma inhibition.Conclusion-15d-PGJ(2) suppressed ischemic brain infarction and neuronal apoptosis and necrosis in a PPAR gamma dependent manner. 15d-PGJ(2) may play a role in controlling acute brain damage induced by ischemia-reperfusion.